Injury-related factors and conditions down-regulate the thrombin receptor (PAR-1) in a human neuronal cell line

Journal of Neurochemistry

Volumn 71, Issue 3, 1998, Pages 1034-1050

  Weinstein, Jonathan R ^a   Lau, Alice L ^a   Brass, Lawrence F ^b   Cunningham, Dennis D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibody; Hypoglycemia; Lysophosphatidic acid; Neurons; PAR 1; Regulation; Thrombin receptor

Indexed keywords

THROMBIN; THROMBIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOGLYCEMIA; LIGAND BINDING; NERVE CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION;

RICKETTSIA SP. PAR;

EID: 0031869126     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71031034.x     Document Type: Article

References (117)

1. Abrahamsen N., Lundgren K., and Nishimura E. (1995) Regulation of glucagon receptor mRNA in cultured primary rat hepatocytes by glucose and cAMP. J. Biol. Chem. 270, 15853-15857.
2. Akiyama H., Ikeda K., Kondo H., and McGeer P. L. (1992) Thrombin accumulation in brains of patients with Alzheimer's disease. Neurol. Lett. 146, 152-154.
3. Baird J. L. and Raper J. A. (1995) A serine proteinase involved in contact mediated repulsion of retinal growth cones by DRG neurites. J. Neurosci. 15, 6605-6618.
4. Beckman G., Beckman L., Ponten J., and Westermark B. (1971 ) G-6-PD and PGM phenotypes of 16 continuous human tumor cell lines. Evidence against cross-contamination and contamination by HeLa cells. Hum. Hered. 21, 238-241.
5. Beecher K. L., Andersen T. T., Fenton J., and Festoff B. W. (1994) Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J. Neurosci. Res. 37, 108-115.
6. Biedler J. L., Helson L., and Spengler B. A. (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652.
7. 2+ in hippocampal neurons. Neuron 9, 285-294.
8. Blackhart B. D., Emilsson K., Nguyen D., Teng W., Martelli A. J., Nystedt S., Sundelin J., and Scarborough R. M. (1996) Ligand cross-reactivity within the protease-activated receptor family. J. Biol. Chem. 271, 16466-16471.
9. Boado R. J. and Pardridge W. M. (1993) Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization. J. Neurochem. 60, 2290-2296.
10. Brass L. F. (1992) Homologous desensitization of HEL cell thrombin receptors. Distinguishable roles for proteolysis and phosphorylation. J. Biol. Chem. 267, 6044-6050.
11. Brass L. F., Vassallo R. Jr., Belmonte E., Ahuja M., Cichowski K., and Hoxie J. A. (1992) Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. J. Biol. Chem. 267, 13795-13798.
12. Brass L. F., Ahuja M., Belmonte E., Blanchard N., Pizarro S., Tarver A., and Hoxie J. A. (1994a) Thrombin receptors: turning them off after turning them on. Semin. Hematol 31, 251-260.
13. Brass L. F., Pizarro S., Ahuja M., Belmonte E., Blanchard N., Stadel J. M., and Hoxie J. A. (1994b) Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J. Biol. Chem. 269, 2943-2952.
14. Brewer G. J. (1995) Exogenous thrombin inhibits neuritogenesis in cultured neuroblastoma cells but not in rat hippocampal neurons. Brain Res. 683, 258-263.
15. Cavanaugh K., Gurwitz D., Cunningham D. D., and Bradshaw R. (1990) Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54, 1735-1743.
16. Chen J., Ishii M., Wang L., Ishii K., and Coughlin S. (1994) Thrombin receptor activation: confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J. Biol. Chem. 269, 16041-16045.
17. Chen X., Berrou J., Nguyen G., Sraer J. D., and Rondeau E. (1995) Endothelin-1 induces rapid and long lasting internalization of the thrombin receptor in human glomerular epithelial cells. Biochem. Biophys. Res. Commun. 217, 445-451.
18. Choi B. H., Suzuki M., Kim T., Wagner S. L., and Cunningham D. D. (1990) Protease nexin-1: localization in the human brain suggests a protective role against extravasated serine proteases. Am. J. Pathol. 137, 741-747.
19. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
20. Cunningham D. D., Pulliam L., and Vaughan P. J. (1993) Protease nexin-1 and thrombin: injury-related processes in the brain. Thromb. Haemost. 70, 168-171.
21. Davis-Salinas J., Saporito-Irwin S. M., Donovan F. M., Cunningham D. D., and Van Nostrand W. E. (1994) Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid beta-protein precursor. J. Biol. Chem. 269, 22623-22627.
22. de Juan J. A., Moya F. J., Garcia de Lacoba M., Fernandez-Cruz A., and Fernandez-Durango R. (1993) Identification and characterization of endothelin receptor subtype B in rat retina. J. Neurochem. 61, 1113-1119.
23. Donovan F. M., Pike C. J., Cotman C. W., and Cunningham D. D. (1997) Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17, 5316-5326.
24. Du J., Sperling L. S., Marrero M. B., Phillips L., and Delafontaine P. (1996) G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin-and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochem. Biophys. Res. Commun. 218, 934-939.
25. Durieux M. E. and Lynch K. R. (1993) Signalling properties of lysophosphatidic acid. Trends Pharmacol Sci. 14, 249-254.
26. Ehrenreich H., Costa T., Clouse K. A., Pluta R. M., Ogino Y., Coligan J. E., and Burd P. R. (1993) Thrombin is a regulator of astrocytic endothelin-1. Brain Res. 600, 201-207.
27. Eichholtz T., Jalink K., Fahrenfort I., and Moolenaar W. H. (1993) The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291, 677-680.
28. Elliott R. C., Inturrisi C. E., Black I. B., and Dreyfus C. F. (1994) An improved method detects differential NGF and BDNF gene expression in response to depolarization in cultured hippocampal neurons. Brain Res. Mol. Brain Res. 26, 81-88.
29. Farmer L., Sommer J., and Monard D. (1990) Glial-derived nexin potentiates neurite extension in hippocampal pyramidal cells in vitro. Dev. Neurosci. 12, 73-80.
30. Galoforo S. S., Berns C. M., Erdos G., Corry P. M., and Lee Y. J. (1996) Hypoglycemia-induced AP-1 transcription factor and basic fibroblast growth factor gene expression in multidrug resistant human breast carcinoma MCF-7/ADR cells. Mol. Cell. Biochem. 155, 163-171.
31. Gerszten R. E., Chen J., Ishii M., Ishii K., Wang L., Nanevicz T., Turck C. W., Vu T. K., and Coughlin S. R. (1994) Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 368, 648-651.
32. Glenn K. C., Carney D. H., Fenton J. W. II, and Cunningham D. D. (1980) Thrombin active site regions required for fibroblast receptor binding and initiation of cell division. J. Biol. Chem. 255, 6609-6616.
33. Grabham P. and Cunningham D. D. (1995) Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation. J. Neurochem. 64, 583-591.
34. Grabham P. W., Grand R. J., Byrd P. J., and Gallimore P. H. (1988) Differentiation of normal and adenovirus-12 E1 transformed human embryo retinal cells. Exp. Eye Res. 47, 123-133.
35. Grand R. J., Grabham P. W., Gallimore M. J., and Gallimore P. H. (1989) Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation. EMBO J. 8, 2209-2215.
36. Grand R. J., Turnell A. S., and Grabham P. W. (1996) Cellular con sequences of thrombin-receptor activation. Biochem. J. 313, 353-368.
37. Guo Z., Liliom K., Fischer D. J., Bathurst I. C., Tomei L. D., Kiefer M. C., and Tigyi G. (1996) Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc. Natl. Acad Sci. USA 93, 14367-14372.
38. Gurwitz D. and Cunningham D. D. (1988) Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl. Acad. Sci. USA 85, 3440-3444.
39. Hecht J. H., Weiner J. A., Post S. R., and Chun J. (1996) Ventricular zone gene-1 (vzg-1 ) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135, 1071-1083.
40. Hein L., Ishii K., Coughlin S. R., and Kobilka B. K. (1994) Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J. Biol. Chem. 269, 27719-27726.
41. Hellmann W., Suzuki F., Ohkubo H., Nakanishi S., Ludwig G., and Ganten D. (1988) Angiotensinogen gene expression in extrahepatic rat tissues: application of a solution hybridization assay. Naunyn Schmiedebergs Arch. Pharmacol. 338, 327-331.
42. Houenou L. J., Turner P. L., Li L., Oppenheim R. W., and Festoff B. W. (1995) A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy induced cell death. Proc. Natl. Acad. Sci. USA 92, 895-899.
43. Hoxie J. A., Ahuja M., Belmonte E., Pizarro S., Parton R., and Brass L. F. (1993) Internalization and recycling of activated thrombin receptors. J. Biol Chem. 268, 13756-13763.
44. Ikeda E., Achen M. G., Breier G., and Risau W. (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270, 19761-19766.
45. Ishihara H., Connolly A. J., Zeng D., Kahn M. L., Zheng Y. W., Timmons C., Tram T., and Coughlin S. R. ( 1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502-506.
46. Ishii K., Hein L., Kobilka B., and Coughlin S. R. (1993) Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J. Biol. Chem. 268, 9780-9786.
47. Ishii K., Chen J., Ishii M., Koch W. J., Freedman N. J., Lefkowitz R. J., and Coughlin S. R. (1994) Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J. Biol. Chem. 269, 1125-1130.
48. Ishii K., Gerszten R., Zheng Y. W., Welsh J. B., Turck C. W., and Coughlin S. R. (1995) Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate. J. Biol. Chem. 270, 16435-16440.
49. Jalink K. and Moolenaar W. H. (1992) Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J. Cell Biol. 118, 411-419.
50. 2(+)-mobilizing stimulus for fibroblasts. Evidence for an extracellular site of action. J. Biol. Chem. 265, 12232-12239.
51. Jalink K., Eichholtz T., Postma F. R., van Corven E. J., and Moolenaar W. H. (1993) Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action. Cell Growth Differ. 4, 247-255.
52. Jalink K., van Corven E. J., Hengeveld T., Morii N., Narumiya S., and Moolenaar W. H. (1994) Inhibition of lysophosphatidate-and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J. Cell Biol. 126, 801-810.
53. Jeng A. Y., Wass K. S., and Hsu L. (1996) Developmental changes in endothelin A and endothelin B receptor subtypes in embryonic chick brains. Neurosci. Lett. 208, 208-210.
54. Klotz I. M. (1982) Numbers of receptor sites from Scatchard graphs: facts and fantasies. Science 217, 1247-1249.
55. Kornecki E. and Ehrlich Y. H. (1988) Neuroregulatory and neuro-pathological actions of the ether-phospholipid platelet-activating factor. Science 240, 1792-1794.
56. Koyama Y. and Baba A. (1994) Endothelins are extracellular signals modulating cytoskeletal actin organization in rat cultured astrocytes. Neuroscience 61, 1007-1016.
57. Lee K. R., Betz A. L., Keep R. F., Chenevert T. L., Kim S., and Hoff J. T. (1995) Intracerebral infusion of thrombin as a cause of brain edema. J. Neurosurg. 83, 1045-1050.
58. Lefkowitz R. J. (1993) G protein-coupled receptor kinases. Cell 74, 409-412.
59. Li F., Baykal D., Horaist C., Yan C. N., Carr B. N., Rao G. N., and Runge M. S. (1996) Cloning and identification of regulatory sequences of the human thrombin receptor gene. J. Biol. Chem. 271, 26320-26328.
60. Liebner S., Gerhardt H., and Wolburg H. (1997) Maturation of the blood-retina barrier in the developing pecten oculi of the chicken. Brain Res. Dev. Brain Res. 100, 205-219.
61. Liu Y., Fields R. D., Festoff B. W., and Nelson P. G. ( 1994) Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc. Natl. Acad. Sci. USA 91, 10300-10304.
62. Mattson M. P. and Scheff S. W. (1994) Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma 11, 3-33.
63. McGeer P. L., Klegeris A., Walker D. G., Yasuhara O., and McGeer E. G. (1994) Pathological proteins in senile plaques. Tohoku J. Exp. Med. 174, 269-277.
64. Miller S., Sehati N., Romano C., and Cotman C. W. (1996) Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5. J. Neurochem. 67, 1435-1447.
65. Molino M., Blanchard N., Belmome E., Tarver A. P., Abrams C., Hoxie J. A., Cerletti C., and Brass L. F. (1995) Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J. Biol. Chem. 270, 11168-11175.
66. Molino M., Bainton D. F., Hoxie J. A., Coughlin S. R., and Brass L. F. (1997) Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation. J. Biol. Chem. 272, 6011-6017.
67. Monard D., Suidan H. S., and Nitsch C. (1992) Relevance of the balance between glia-derived nexin and thrombin following lesion in the nervous system. Ann. NY Acad. Sci. 674, 237-242.
68. Moolenaar W. H. (1995a) Lysophosphatidic acid signalling. Curr. Opin. Cell Biol. 7, 203-210.
69. Moolenaar W. H. (1995b) Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270, 12949-12952.
70. Morris G. M., Hadcock J. R., and Malbon C. C. (1991) Cross-regulation between G-protein-couplcd receptors. Activation of beta 2-adrenergic receptors increases alpha 1-adrenergic receptor mRNA levels. J. Biol. Chem. 266, 2233-2238.
71. Murphy S. and Welk G. (1990) Hydrolysis of polyphosphoinositides in astrocytes by platelet-activating factor. Eur. J. Pharmacol. 188, 399-401.
72. Naveilhan P., Neveu I., Jehan F., Baudet C., Wion D., and Brachet P. (1994) Reactive oxygen species influence nerve growth factor synthesis in primary rat astrocytes. J. Neurochem. 62, 2178-2186.
73. Nelson R. B. and Simon R. (1990) Thrombin and its inhibitors regulate morphological and biochemical differentiation of astrocytes in vitro. Brain Res. Dev. Brain Res. 54, 93-104.
74. Neveu I., Jehan F., Jandrot-Perrus M., Wion D., and Brachet P. (1993) Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases: a possible involvement of thrombin. J. Neurochem. 60, 858-867.
75. Niclou S., Suidan H., Brown-Luedi M., and Monard D. (1994) Expression of the thrombin receptor mRNA in rat brain. Cell. Mol. Biol. 40, 421-428.
76. Nishino A., Suzuki M., Ohtani H., Motohashi O., Umezawa K., Nagura H., and Yoshimoto T. (1993 ) Thrombin may contribute to the pathophysiology of central nervous injury. J. Neurotrauma 10, 167-179.
77. Norton K. J., Scarborough R. M., Kutok J. L., Escobedo M. A., Nannizzi L., and Coller B. S. (1993) Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment. Blood 82, 2125-2136.
78. Nystedt S., Emilsson K., Wahlestedt C., and Sundelin J. (1994) Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. USA 91, 9208-9212.
79. Nystedt S., Ramakrishnan V., and Sundelin J. (1996) The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J. Biol. Chem. 271, 14910-14915.
80. Paris S., Magnaldo I., and Pouyssegur J. (1988) Homologous desensitization of thrombin-induced phosphoinositide breakdown in hamster lung fibroblasts. J. Biol. Chem. 263, 11250-11256.
81. Pike C. J., Vaughan P. J., Cunningham D. D., and Cotman C. W. (1996) Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by β-amyloid in vitro. J. Neurochem. 66, 1374-1382.
82. Pitcher J., Lohse M. J., Codina J., Caron M. G., and Lefkowitz R. J. (1992) Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. Biochemistry 31, 3193-3197.
83. Ponten J. and Macintyre E. H. (1968) Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand. 74, 465-486.
84. Port J. D., Hadcock J. R., and Malbon C. C. (1992) Cross-regulation between G-protein-mediated pathways. Acute activation of the inhibitory pathway of adenylylcyclase reduces beta 2-adrenergic receptor phosphorylation and increases beta-adrenergic responsiveness. J. Biol. Chem. 267, 8468-8472.
85. Puro D. G. and Stuenkel E. L. (1995) Thrombin-induced inhibition of potassium currents in human retinal glial (Muller) cells. J. Physiol. (Lond.) 485, 337-348.
86. Rao G. N., Delafontaine P., and Runge M. S. ( 1995 ) Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth muscle cells. J. Biol. Chem. 270, 27871-27875.
87. 2+ mobilization. FEBS Lett. 288, 123-128.
88. Scarborough R. M., Naughton M. A., Teng W., Hung D. T., Rose J., Vu T. K., Wheaton V. I., Turck C. W., and Coughlin S. R. (1992) Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanisms of proteolytic unmasking of agonist function. J. Biol. Chem. 267, 13146-13149.
89. Scorsone K. A., Panniers R., Rowlands A. G., and Henshaw E. C. (1987) Phosphorylation of eukaryotic initiation factor 2 during physiological stresses which affect protein synthesis. J. Biol. Chem. 262, 14538-14543.
90. Shapiro M. J., Trejo J., Zeng D., and Coughlin S. R. (1996) Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J. Biol. Chem. 271, 32874-32880.
91. 2+ homeostasis and sensitivity to glucose deprivation-induced injury. J. Neurosci. 15, 5840-5850.
92. Soifer S. J., Peters K. G., O'Keefe J., and Coughlin S. R. (1994) Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am. J. Pathol. 144, 60-69.
93. Stein I., Neeman M., Shweiki D., Itin A., and Keshet E. (1995) Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15, 5363-5368.
94. Storck J. and Zimmermann E. R. (1996) Regulation of the thrombin receptor response in human endothelial cells. Thromb. Res. 81, 121-131.
95. Suidan H. S., Stone S. R., Hemmings B. A., and Monard D. (1992) Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 8, 363-375.
96. Suidan H. S., Bouvier J., Schaerer E., Stone S. R., Monard D., and Tschopp J. (1994) Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. PTOC. Natl. Acad. Sci. USA 91, 8112-8116.
97. Suidan H. S., Niclou S. P., Dreessen J., Beltraminelli N., and Monard D. (1996a) The thrombin receptor is present in myoblasts and its expression is repressed upon fusion. J. Biol. Chem. 271, 29162-29169.
98. Suidan H. S., Niclou S. P., and Monard D. (1996b) The thrombin receptor in the nervous system. Semin. Thromb. Hemost. 22, 125-133.
99. Takahashi K., Brooks R. A., Kanse S. M., Ghatei M. A., Kohner E. M., and Bloom S. R. (1989) Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes. Diabetes 38, 1200-1202.
100. Takei K., Sato T., Nonoyama T., Hommura S., Miyauchi T., and Goto K. (1993) Analysis of vasocontractile responses to endothelin-1 in rabbit retinal vessels using an ETA receptor antagonist and an ETB receptor agonist. Life Sci. 53, L111-L115.
101. Tigyi G. and Miledi R. (1992) Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J. Biol. Chem. 267, 21360-21367.
102. Tong L. and Perez-Polo J. R. (1995) Transcription factor DNA binding activity in PC12 cells undergoing apoptosis after glucose deprivation. Neurosci. Lett. 191, 137-140.
103. van Venrooij W., Henshaw, E. C., and Hirsch C. A. (1972) Effects of deprival of glucose or individual amino acids on polyribosome distribution and rate of protein synthesis in cultured mammalian cells. Biochim. Biophys. Acta 259, 127-137.
104. Vaughan P. J., Pike C. J., Cotman C. W., and Cunningham D. D. (1995) Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci 15, 5389-5401.
105. Vouret-Craviari V., Auberger P., Pouyssegur J., and Van Obberghen-Schilling E. (1995) Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization. J. Biol. Chem. 270, 4813-4821.
106. Vu T. K., Hung D. T., Wheaton V. I., and Coughlin S. R. (1991a) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068.
107. Vu T. K., Wheaton V. I., Hung D. T., Charo I., and Coughlin S. R. (1991b) Domains specifying thrombin-receptor interaction. Nature 353, 674-677.
108. Vuvan T., Geffard M., Denis P., Simon A., and Nguyen-Legros J. (1993) Radioimmunoligand characterization and immunohistochemical localization of dopamine D2 receptors on rods in the rat retina. Brain Res. 614, 57-64.
109. Weinstein J. R., Gold S. J., Cunningham D. D., and Gall C. M. (1995) Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15, 2906-2919.
110. Witkovsky P. and Dearry A. (1991) Functional roles of dopamine in the vertebrate retina, in Progress in Retinal Research (Osborne N. and Chader G., eds), pp. 247-292. Pergamon, Oxford.
111. Woolkalis M. J., DeMelfi T. Jr., Blanchard N., Hoxie J. A., and Brass L. F. (1995) Regulation of thrombin receptors on human umbilical vein endothelial cells. J. Biol. Chem. 270, 9868-9875
112. Van W., Tiruppathi C., Qiao R., Lum H., and Malik A. B. (1996) Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. J. Cell. Physiol. 166, 561-567.
113. Yang Y., Akiyama H., Fenton J. W. N., and Brewer G. J. (1997) Thrombin receptor on rat primary hippocampal neurons: coupled calcium and cAMP responses. Brain Res. 761, 11-18.
114. Yang Z., Cohen R. L., Lui G. M., Lawrence D. A., and Shuman M. A. (1995) Thrombin increases expression of urokinase receptor by activation of the thrombin receptor. Invest. Ophthalmol. Vis. Sci. 36, 2254-2261.
115. Zacharias U., He C. J., Hagege J., Xu Y., Sraer J. D., Brass L. F., and Rondeau E. (1995a) Thrombin and phorbol ester induce internalization of thrombin receptor of human mesangial cells through different pathways. Exp. Cell Res. 216, 371-379.
116. Zacharias U., Xu Y., Hagege J., Sraer J. D., Brass L. F., and Rondeau E. (1995b) Thrombin, phorbol ester, and cAMP regulate thrombin receptor protein and mRNA expression by different pathways. J. Biol. Chem. 270, 545-550.
117. Zhong C., Hayzer D. J., Corson M. A., and Runge M. S. (1992) Molecular cloning of the rat vascular smooth muscle thrombin receptor Evidence for in vitro regulation by basic fibroblast growth factor. J. Biol. Chem. 267, 16975-16979.